Novavax Inc

Затворен

СекторЗдравеопазване

10.09 1.2

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

9.75

Максимум

10.14

Ключови измерители

By Trading Economics

Приходи

-44M

-53M

Продажби

-83M

57M

P/E

Средно за сектора

3.112

56.432

EPS

-0.32

Марж на печалбата

-94.16

Служители

749

EBITDA

-39M

-40M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+12.1% upside

Дивиденти

By Acuity

Следващи печалби

5.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

363M

1.6B

Предишно отваряне

8.89

Предишно затваряне

10.09

Настроения в новините

By Acuity

50%

50%

120 / 339 Класиране в Healthcare

Novavax Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.09.2026 г., 20:06 ч. UTC

Novavax Inc shares are higher in Friday's trading session, recovering from mid-morning lows and maintaining a position above the 20-day moving average.

17.09.2026 г., 20:02 ч. UTC

Novavax Inc is advancing, continuing sharp gains since Wednesday, despite earlier pulling back from a session high amid broader market weakness.

16.09.2026 г., 23:21 ч. UTC

Novavax Inc's stock is modestly lower in after-market trading, following earlier volatility and currently trading below its 20-day moving average.

15.09.2026 г., 22:51 ч. UTC

Novavax Inc. shares are lower in after-market hours, reflecting broader economic concerns following a decline in the NY Empire State Manufacturing Index.

14.09.2026 г., 23:36 ч. UTC

Novavax shares are trading lower in after-market hours, following a broader decline in U.S. stocks amid rising crude oil prices and supply concerns.

11.09.2026 г., 20:08 ч. UTC

Novavax Inc. shares are higher during Friday's session, having reached a session high earlier before pulling back. No specific news was identified.

10.09.2026 г., 23:01 ч. UTC

Novavax Inc. shares are lower in after-market hours, continuing recent downward trends. The stock reached its lowest point shortly after the market reopened.

9.09.2026 г., 19:46 ч. UTC

Social Media

Novavax Inc shares are lower amid ongoing volatility following first-quarter results. The stock has faced pressure, dipping below $11.50 earlier in the session.

8.09.2026 г., 19:26 ч. UTC

Novavax Inc. shares are trading roughly flat, reflecting minimal change since Friday's close amid broader market trends. The asset remains above its 20-day moving average.

4.09.2026 г., 23:15 ч. UTC

Novavax Inc. shares are lower in after-market hours, reflecting a slight decline since Friday's close amid rising Treasury yields and interest rate expectations.

3.09.2026 г., 23:05 ч. UTC

Novavax Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average and showing significant gains from a month ago.

2.09.2026 г., 23:06 ч. UTC

Novavax Inc. shares are trading roughly flat in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

1.09.2026 г., 23:31 ч. UTC

Novavax Inc. shares are lower in after-market trading, showing volatility since Tuesday's close, though the stock remains well above its 20-day moving average.

31.08.2026 г., 23:01 ч. UTC

Novavax Inc shares are higher in after-market trading, continuing a strong three-session performance. No specific news was identified to explain the movement.

28.08.2026 г., 23:01 ч. UTC

Novavax Inc shares declined in after-market trading, amid rising market expectations for an interest rate hike and upward pressure on Treasury yields.

27.08.2026 г., 23:01 ч. UTC

Novavax Inc. shares are higher in after-market trading, rebounding from earlier volatility and remaining above the 20-day moving average.

26.08.2026 г., 20:08 ч. UTC

Novavax Inc shares are lower as the biotechnology sector declines. The stock rebounded earlier in the session but has since pulled back.

25.08.2026 г., 20:07 ч. UTC

Novavax Inc shares are higher Tuesday, supported by lower Treasury yields. The stock pulled back from an intraday high but remains up since Monday.

24.08.2026 г., 20:04 ч. UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

21.08.2026 г., 23:31 ч. UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

20.08.2026 г., 19:02 ч. UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

19.08.2026 г., 23:51 ч. UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

17.08.2026 г., 19:36 ч. UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

14.08.2026 г., 23:26 ч. UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

13.08.2026 г., 19:16 ч. UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

12.08.2026 г., 23:31 ч. UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

11.08.2026 г., 23:51 ч. UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

10.08.2026 г., 23:46 ч. UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

7.08.2026 г., 19:36 ч. UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

6.08.2026 г., 23:01 ч. UTC

News

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

Сравнение с други в отрасъла

Ценова промяна

Novavax Inc Прогноза

Ценова цел

By TipRanks

12.1% нагоре

12-месечна прогноза

Среден 11.333 USD  12.1%

Висок 18 USD

Нисък 7 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Novavax Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

3 ratings

1

Купи

1

Задържане

1

Продай

Настроение

By Acuity

120 / 339 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.